IP Library Granted Patent US 9,382,281
Granted Patent B2
US 9,382,281 · App. 14/535,854 · Granted Jul 5, 2016

Nickel pre-catalysts and related compositions and methods

Inventors: Timothy F. Jamison (Somerville, MA); Eric Alan Standley (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
C07F15/04B01J31/24B01J31/2409B01J31/2414B01J2231/34B01J2531/847
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,382,281
App. No.
14/535,854
Granted
Jul 5, 2016
Kind
B2
Abstract

Described herein are nickel pre-catalysts and related compositions and methods. The nickel pre-catalysts may be activated to form catalysts which may be utilized in organic reactions.

Claims (50)

1. A pre-catalyst, comprising:

a nickel (II) atom, wherein the nickel (II) atom is associated with at least one phosphine ligand; at least one aryl ligand; and at least one leaving group, wherein one or more of the ligands is chiral.

2. The pre-catalyst of claim 1 , wherein the pre-catalyst comprises two phosphine ligands.

3. The pre-catalyst of claim 1 , wherein the pre-catalyst comprises two phosphine ligands, one aryl ligand, and one leaving group.

4. The pre-catalyst of claim 2 , wherein the two phosphine ligands are trans.

5. The pre-catalyst of claim 2 , wherein the two phosphine ligands are cis.

6. The pre-catalyst of claim 2 , the two phosphine ligands are monodentate.

7. The pre-catalyst of claim 1 , wherein the pre-catalyst has the structure:

wherein each R 1 is independently optionally substituted alkyl, optionally substituted cycloalkyl, or optionally substituted aryl, or any two R 1 may be joined together to form a ring;

Ar is the at least one aryl ligand, and LG is the at least one leaving group.

8. The pre-catalyst of claim 1 , wherein the pre-catalyst has the structure:

wherein each R 2 is independently optionally substituted alkyl, optionally substituted cycloalkyl, or optionally substituted aryl, or any two R 2 are joined together to form a ring;

each R 3 is —O—, optionally substituted alkylene, optionally substituted heteroalkylene, optionally substituted arylene, optionally substituted heteroarylene, or optionally substituted ferrocenylene;

n is 1, 2, 3, 4, 5, or 6; Ar is the at least one aryl ligand; and

LG is the at least one leaving group.

9. The pre-catalyst of claim 1 , wherein the pre-catalyst is not:

10. A pre-catalyst, comprising:

a nickel (II) atom, wherein the nickel (II) atom is associated with at least one N-heterocyclic carbene ligand; at least one aryl ligand; and at least one leaving group.

11. The pre-catalyst of claim 10 , wherein the pre-catalyst further comprises at least one phosphine ligand.

12. The pre-catalyst of claim 10 , wherein the pre-catalyst comprises one heterocyclic carbene ligand, one phosphine ligand, one aryl ligand, and one leaving group.

13. The pre-catalyst of claim 11 , wherein the phosphine ligand is monodentate.

14. The pre-catalyst of claim 1 , wherein each monodentate phosphine ligand is the same or different and has the structure P(R 1 ) 3 , wherein each R 1 is independently optionally substituted alkyl, optionally substituted cycloalkyl, or optionally substituted aryl.

15. The pre-catalyst of claim 1 , wherein the pre-catalyst comprises a bidentate phosphine ligand.

16. The pre-catalyst of claim 15 , wherein the bidentate phosphine ligand has the structure (R 2 ) 2 P—(R 3 ) n —P(R 2 ) 2 , wherein each R 2 is independently optionally substituted alkyl, optionally substituted cycloalkyl, or optionally substituted aryl, or any two R 2 can be joined together to form a ring; each R 3 is —O—, optionally substituted alkylene, optionally substituted heteroalkylene, optionally substituted arylene, optionally substituted heteroarylene, or optionally substituted ferrocenylene; and n is 1, 2, 3, 4, 5, or 6.

17. The pre-catalyst of claim 1 , wherein the aryl ligand is substituted at one or both ortho positions.

18. The pre-catalyst of claim 1 , wherein the leaving group is selected from the group consisting of halo, OTs, and OMs.

19. A method, comprising:

activating a pre-catalyst as in claim 1 to form a catalyst.

20. A compound selected from the group consisting of trans-(PPh 3 ) 2 Ni(o-tolyl)Cl, trans-(PCyPh 2 ) 2 Ni(o-tolyl)Cl, trans-(PCy 2 Ph) 2 Ni(o-tolyl)Cl, trans-(PCy 3 ) 2 Ni(o-tolyl)Cl, trans-(PCy 3 ) 2 Ni(o-tolyl)Cl, trans-(PCy 3 ) 2 Ni(o-tolyl)Cl, trans-(PCyp 3 ) 2 Ni(o-tolyl)Cl, trans-(PCyp 3 ) 2 Ni(o-tolyl)Cl, trans-(PBn 3 ) 2 Ni(o-tolyl)Cl, trans-(PBn 3 ) 2 Ni(o-tolyl)Cl, trans-(PMe 2 Ph) 2 Ni(o-tolyl)Cl, trans-(PMe 2 Ph) 2 Ni(2,4,6-triisopropylphenyl)Br, trans-(PMe 2 Ph) 2 Ni(2,6-dimethoxyphenyl)Br, trans-(PEt 3 ) 2 Ni(2-mesityl)Br, trans-(PnBu 3 ) 2 Ni(2-mesityl)Br, cis-[dppe]Ni(o-tolyl)Cl, cis-[dppp]Ni(2-mesityl)Br, trans-[dppb]Ni(2-mesityl)Br, cis-[(S)-BINAP]Ni(o-tolyl)Cl, cis-[dppf]Ni(o-tolyl)Cl, trans-[dcpf]Ni(o-tolyl)Cl, trans-[xantphos]Ni(o-tolyl)Cl, and cis-[pyphos]Ni(o-tolyl)Cl, wherein:

Cy is cyclohexyl,

Cyp is cyclopentyl,

Bn is benzyl,

dppe is 1,2-bis(diphenylphosphino)ethane,

dppp is 1,3-bis(diphenylphosphino)propane,

dppb is 1,4-bis(diphenylphosphino)butane,

BINAP is 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl,

dppf is 1,1′-bis(diphenylphosphino)ferrocene,

dcpf is 1,1′-bis(dicyclohexylphosphino)ferrocene,

xantphos is 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene, and

pyphos is 2-[2-(diphenylphosphino)ethyl]pyridine.

21. The compound of claim 20 , wherein the compound is trans-(PCy 3 ) 2 Ni(o-tolyl)Cl, wherein Cy is cyclohexyl.

22. The compound of claim 20 , wherein the compound is trans-(PCy 2 Ph) 2 Ni(o-tolyl)Cl, wherein Cy is cyclohexyl.

23. The compound of claim 20 , wherein the compound is trans-(PCyp 3 ) 2 Ni(o-tolyl)Cl, wherein Cyp is cyclopentyl.

24. The compound of claim 20 , wherein the compound is trans-(PEt 3 ) 2 Ni(2-mesityl)Br.

25. The compound of claim 20 , wherein the compound is trans-(PBn 3 ) 2 Ni(o-tolyl)Cl, wherein Bn is benzyl.

26. The compound of claim 20 , wherein the compound is trans-(PPh 2 Me) 2 Ni(o-tolyl)Cl.

27. The compound of claim 20 , wherein the compound is cis-(dppe)Ni(o-tolyl)Cl, wherein dppe is 1,2-bis(diphenylphosphino)ethane.

28. The compound of claim 20 , wherein the compound is cis-[(S)-BINAP)]Ni(o-tolyl)Cl, wherein BINAP is 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl.

29. A method, comprising:

activating a pre-catalyst as in claim 20 to form a catalyst.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 9, 2015
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036580/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2015
From: JAMISON, TIMOTHY F; STANDLEY, ERIC ALAN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 035587/0868 →
Continuity (2)
Provisional Application 61902484 · Nov 11, 2013
Related Publication 20150141684A1 · May 21, 2015